Glenmark Pharmaceuticals releases Q1 2025 earnings call transcript
Glenmark Pharmaceuticals Limited announced on August 28, 2025, the release of the transcript from its earnings call for the first quarter ended June 30, 2025. This disclosure follows a letter dated August 8, 2025, and complies with Regulation 30(6) read with Part A of Schedule III of SEBI (LODR), Regulations 2015. The earnings call was held on Monday, August 18, 2025.
The complete transcript has been uploaded to the company's website at https://glenmark.b-cdn.net/gpl_pdfs/investors/reports_presentations/earning_concall/Glenmark-Earnings%20Transcript-18%20Aug%202025.pdf. The company has requested that the regulatory bodies officially record this submission.
The announcement was signed by Harish Kuber, company secretary & compliance officer. The registered office for Glenmark Pharmaceuticals Limited is B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Glenmark Pharmaceuticals publishes news
Free account required • Unsubscribe anytime